<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02391090</url>
  </required_header>
  <id_info>
    <org_study_id>MUG-FeNO-2013</org_study_id>
    <nct_id>NCT02391090</nct_id>
  </id_info>
  <brief_title>FeNO After Hypoxia in Asthma Patients</brief_title>
  <official_title>Effects of Intermittent Hypoxia on the Asthmatic Inflammation of Asthma Patients - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ludwig Boltzmann Institute of Lung Vascular Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stable Asthma patients (GINA 1-2) stay 6 days in a row for 4 hours per day in a hypoxic
      chamber simulating 2800m above sea level. Study participants will be blinded to the treatment
      given and divided into a hypoxic and a sham group (about 360m above sea level).

      Effects of this intermittent hypoxia on the asthmatic inflammation of these patients will be
      measured. The primary endpoint is the change in forced exhaled nitric oxide (FeNO) before and
      after the study. Secondary endpoints include blood parameters, lung function testing and
      questionnaires.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in forced exhaled nitric oxide after 6 days of hypoxia/sham</measure>
    <time_frame>1 week</time_frame>
    <description>Forced exhaled nitric oxide will be measured every day before and after the treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in blood parameters after 6 days of hypoxia/sham</measure>
    <time_frame>1 week</time_frame>
    <description>Blood parameters including c-reactive protein, complete blood cell count, total immunoglobulin e (IgE), specific IgE of seasonal inhalative antigens and eosinophilic cationic protein will be measured. Blood samples will be taken before the first and after the last intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lung function parameters after 6 days of hypoxia/sham</measure>
    <time_frame>1 week</time_frame>
    <description>Lung function testing will be performed before the first and after the last intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life and Asthma questionnaires after 6 days of hypoxia/sham</measure>
    <time_frame>1 week</time_frame>
    <description>Questionnaires include Asthma Control Test, Asthma Quality of Life Questionnaire, Asthma Control Questionnaire, a quality of life questionnaire and the Asthma Control Diary. Documents will be collected every day before the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in finger pulse oximetry</measure>
    <time_frame>1 week</time_frame>
    <description>Finger pulse oximetry will be measured hourly during the intervention for safety reasons.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>hypoxia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The hypoxia group receives normobaric hypoxic air while sitting in a hypoxic chamber simulating 2800 meter above sea level.
Interventions: hypoxia in hypoxic chamber, asthma and Quality of Life Questionnaires, lung function testing, blood taking, FeNO measurement, pulse oximetry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham hypoxia</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The sham group receives normal air while sitting in a hypoxic chamber in about 360 meter above sea level (Graz, Austria).
Interventions: sham hypoxia in hypoxic chamber, asthma and Quality of Life Questionnaires, lung function testing, blood taking, FeNO measurement, pulse oximetry</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hypoxia in hypoxic chamber</intervention_name>
    <description>Intervention lasts 4 hours per day for 6 days in a row.</description>
    <arm_group_label>hypoxia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham hypoxia in hypoxic chamber</intervention_name>
    <description>Intervention lasts 4 hours per day for 6 days in a row.</description>
    <arm_group_label>sham hypoxia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulse oximetry</intervention_name>
    <description>Pulse oximetry will be performed hourly during sessions in the hypoxic chamber for safety reasons.</description>
    <arm_group_label>hypoxia</arm_group_label>
    <arm_group_label>sham hypoxia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Asthma and Quality of Life Questionnaires</intervention_name>
    <description>Before every session in the hypoxic chamber as well as on the day after the last session will be completed.</description>
    <arm_group_label>hypoxia</arm_group_label>
    <arm_group_label>sham hypoxia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lung function testing</intervention_name>
    <description>On the day of the first session in the hypoxic chamber as well as on the day after the last session lung function testing will be performed.</description>
    <arm_group_label>hypoxia</arm_group_label>
    <arm_group_label>sham hypoxia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood taking</intervention_name>
    <description>On the day of the first session in the hypoxic chamber as well as on the day after the last session blood samples will be taken.</description>
    <arm_group_label>hypoxia</arm_group_label>
    <arm_group_label>sham hypoxia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FeNO measurement</intervention_name>
    <description>Before every session in the hypoxic chamber as well as on the day after the last session FeNO (forced exhaled nitric oxide) measurement will be performed.</description>
    <arm_group_label>hypoxia</arm_group_label>
    <arm_group_label>sham hypoxia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stable Asthma (GINA 1-2)

        Exclusion Criteria:

          -  autoimmune disease

          -  unstable Asthma (GINA 3-4)

          -  history of pneumonia/fever within 3 months

          -  place of residence &gt;1000m above sea level

          -  trip/vacation above &gt;2500m within 4 weeks

          -  cystic fibrosis

          -  diabetes mellitus

          -  immunodeficiency

          -  atopic dermatitis

          -  ciliary dyskinesia

          -  pregnancy

          -  chronic obstructive pulmonary disease

          -  history of smoking (&gt;1py)

          -  immunosuppression / systemic corticosteroids within 3 months

          -  cardiovascular diseases

          -  interstitial lung disease

          -  bronchopulmonary dysplasia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Horst Olschewski, MD, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz, Department of Internal Medicine, Division of Pulmonology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2015</study_first_submitted>
  <study_first_submitted_qc>March 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2015</study_first_posted>
  <last_update_submitted>March 11, 2015</last_update_submitted>
  <last_update_submitted_qc>March 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>hypoxia</keyword>
  <keyword>forced exhaled nitric oxide</keyword>
  <keyword>inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

